Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 313 (5795): 1929-1935

Copyright © 2006 by the American Association for the Advancement of Science

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Justin Lamb,1* Emily D. Crawford,1{dagger} David Peck,1 Joshua W. Modell,1 Irene C. Blat,1 Matthew J. Wrobel,1 Jim Lerner,1 Jean-Philippe Brunet,1 Aravind Subramanian,1 Kenneth N. Ross,1 Michael Reich,1 Haley Hieronymus,1,2 Guo Wei,1,2 Scott A. Armstrong,2,3 Stephen J. Haggarty,1,4 Paul A. Clemons,1 Ru Wei,1 Steven A. Carr,1 Eric S. Lander,1,5,6 Todd R. Golub1,2,3,5,7*

Abstract: To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this "Connectivity Map" resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.

1 Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
2 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
3 Department of Medicine, Children's Hospital Boston, Boston, MA 02115, USA.
4 Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02144, USA.
5 Harvard Medical School, Boston, MA 02115, USA.
6 Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
7 Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

{dagger} Present address: University of California, San Francisco, CA 94158, USA.

* To whom correspondence should be addressed. E-mail: golub{at}broad.harvard.edu, justin{at}broad.mit.edu


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Subpathway-Based Method of Drug Reposition for Polycystic Ovary Syndrome.
H.-Y. Liu, J.-Q. Liu, Z.-X. Mai, and Y.-T. Zeng (2014)
Reproductive Sciences
   Abstract »    Full Text »    PDF »
DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections.
C.-C. Liu, Y.-T. Tseng, W. Li, C.-Y. Wu, I. Mayzus, A. Rzhetsky, F. Sun, M. Waterman, J. J. W. Chen, P. M. Chaudhary, et al. (2014)
Nucleic Acids Res. 42, W137-W146
   Abstract »    Full Text »    PDF »
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures.
Q. Duan, C. Flynn, M. Niepel, M. Hafner, J. L. Muhlich, N. F. Fernandez, A. D. Rouillard, C. M. Tan, E. Y. Chen, T. R. Golub, et al. (2014)
Nucleic Acids Res. 42, W449-W460
   Abstract »    Full Text »    PDF »
Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer.
L. F. Zerbini, M. K. Bhasin, J. F. de Vasconcellos, J. D. Paccez, X. Gu, A. L. Kung, and T. A. Libermann (2014)
Mol. Cancer Ther. 13, 1929-1941
   Abstract »    Full Text »    PDF »
MGDB: crossing the marker genes of a user microarray with a database of public-microarrays marker genes.
M. Huerta, M. Munyi, D. Exposito, E. Querol, and J. Cedano (2014)
Bioinformatics 30, 1780-1781
   Abstract »    Full Text »    PDF »
Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis.
D. Carrella, F. Napolitano, R. Rispoli, M. Miglietta, A. Carissimo, L. Cutillo, F. Sirci, F. Gregoretti, and D. Di Bernardo (2014)
Bioinformatics 30, 1787-1788
   Abstract »    Full Text »    PDF »
DrugComboRanker: drug combination discovery based on target network analysis.
L. Huang, F. Li, J. Sheng, X. Xia, J. Ma, M. Zhan, and S. T. C. Wong (2014)
Bioinformatics 30, i228-i236
   Abstract »    Full Text »    PDF »
Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses.
V. Dančik, H. Carrel, N. E. Bodycombe, K. P. Seiler, D. Fomina-Yadlin, S. T. Kubicek, K. Hartwell, A. F. Shamji, B. K. Wagner, and P. A. Clemons (2014)
J Biomol Screen 19, 771-781
   Abstract »    Full Text »    PDF »
Automated Structure-Activity Relationship Mining: Connecting Chemical Structure to Biological Profiles.
M. J. Wawer, D. E. Jaramillo, V. Dančik, D. M. Fass, S. J. Haggarty, A. F. Shamji, B. K. Wagner, S. L. Schreiber, and P. A. Clemons (2014)
J Biomol Screen 19, 738-748
   Abstract »    Full Text »    PDF »
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer.
S. Jaeger, J. Min, F. Nigsch, M. Camargo, J. Hutz, A. Cornett, S. Cleaver, A. Buckler, and J. L. Jenkins (2014)
J Biomol Screen 19, 791-802
   Abstract »    Full Text »    PDF »
Systems-based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy.
M. C. Dyle, S. M. Ebert, D. P. Cook, S. D. Kunkel, D. K. Fox, K. S. Bongers, S. A. Bullard, J. M. Dierdorff, and C. M. Adams (2014)
J. Biol. Chem. 289, 14913-14924
   Abstract »    Full Text »    PDF »
Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer.
E. E. Gardner, N. Connis, J. T. Poirier, L. Cope, I. Dobromilskaya, G. L. Gallia, C. M. Rudin, and C. L. Hann (2014)
Cancer Res. 74, 2846-2856
   Abstract »    Full Text »    PDF »
Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding.
M. Iskar, G. Zeller, P. Blattmann, M. Campillos, M. Kuhn, K. H. Kaminska, H. Runz, A.-C. Gavin, R. Pepperkok, V. van Noort, et al. (2014)
Mol Syst Biol 9, 662
   Abstract »    Full Text »    PDF »
Protein localization as a principal feature of the etiology and comorbidity of genetic diseases.
S. Park, J.-S. Yang, Y.-E. Shin, J. Park, S. K. Jang, and S. Kim (2014)
Mol Syst Biol 7, 494
   Abstract »    Full Text »    PDF »
PREDICT: a method for inferring novel drug indications with application to personalized medicine.
A. Gottlieb, G. Y. Stein, E. Ruppin, and R. Sharan (2014)
Mol Syst Biol 7, 496
   Abstract »    Full Text »    PDF »
A pharmacogenomic method for individualized prediction of drug sensitivity.
A. L. Cohen, R. Soldi, H. Zhang, A. M. Gustafson, R. Wilcox, B. E. Welm, J. T. Chang, E. Johnson, A. Spira, S. S. Jeffrey, et al. (2014)
Mol Syst Biol 7, 513
   Abstract »    Full Text »    PDF »
Ribonucleoprotein dynamics connects mRNA networks with drug mechanisms.
M. Gorospe (2014)
Mol Syst Biol 5, 289
   Full Text »    PDF »
Disease signatures are robust across tissues and experiments.
J. T. Dudley, R. Tibshirani, T. Deshpande, and A. J. Butte (2014)
Mol Syst Biol 5, 307
   Abstract »    Full Text »    PDF »
Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action.
L. Kapitzky, P. Beltrao, T. J. Berens, N. Gassner, C. Zhou, A. Wuster, J. Wu, M. M. Babu, S. J. Elledge, D. Toczyski, et al. (2014)
Mol Syst Biol 6, 451
   Abstract »    Full Text »    PDF »
Identifying regulatory mechanisms underlying tumorigenesis using locus expression signature analysis.
E. Lee, J. de Ridder, J. Kool, L. F. A. Wessels, and H. J. Bussemaker (2014)
PNAS 111, 5747-5752
   Abstract »    Full Text »    PDF »
A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas.
K. M. Mani, C. Lefebvre, K. Wang, W. K. Lim, K. Basso, R. Dalla-Favera, and A. Califano (2014)
Mol Syst Biol 4, 169
   Abstract »    Full Text »    PDF »
The liver pharmacological and xenobiotic gene response repertoire.
G. Natsoulis, C. I. Pearson, J. Gollub, B. P Eynon, J. Ferng, R. Nair, R. Idury, M. D. Lee, M. R. Fielden, R. J. Brennan, et al. (2014)
Mol Syst Biol 4, 175
   Abstract »    Full Text »    PDF »
Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures.
A. Y. Lee, R. P. St.Onge, M. J. Proctor, I. M. Wallace, A. H. Nile, P. A. Spagnuolo, Y. Jitkova, M. Gronda, Y. Wu, M. K. Kim, et al. (2014)
Science 344, 208-211
   Abstract »    Full Text »    PDF »
The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells.
K. Komurov, J.-T. Tseng, M. Muller, E. G. Seviour, T. J. Moss, L. Yang, D. Nagrath, and P. T. Ram (2014)
Mol Syst Biol 8, 596
   Abstract »    Full Text »    PDF »
The gene signature in CCAAT-enhancer-binding protein {alpha} dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors.
A. Liss, C.-H. Ooi, P. Zjablovskaja, T. Benoukraf, H. S. Radomska, C. Ju, M. Wu, M. Balastik, R. Delwel, T. Brdicka, et al. (2014)
Haematologica 99, 697-705
   Abstract »    Full Text »    PDF »
Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.
F. Meng, E. Dai, X. Yu, Y. Zhang, X. Chen, X. Liu, S. Wang, L. Wang, and W. Jiang (2014)
J R Soc Interface 11, 20131057
   Abstract »    Full Text »    PDF »
Phenotypic Profiling of Antibiotic Response Signatures in Escherichia coli Using Raman Spectroscopy.
A. I. M. Athamneh, R. A. Alajlouni, R. S. Wallace, M. N. Seleem, and R. S. Senger (2014)
Antimicrob. Agents Chemother. 58, 1302-1314
   Abstract »    Full Text »    PDF »
Causal analysis approaches in Ingenuity Pathway Analysis.
A. Kramer, J. Green, J. Pollard Jr, and S. Tugendreich (2014)
Bioinformatics 30, 523-530
   Abstract »    Full Text »    PDF »
Identification of transcription factors for drug-associated gene modules and biomedical implications.
M. Xiong, B. Li, Q. Zhu, Y.-X. Wang, and H.-Y. Zhang (2014)
Bioinformatics 30, 305-309
   Abstract »    Full Text »    PDF »
Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents.
V. K. Yadav, A. Kumar, A. Mann, S. Aggarwal, M. Kumar, S. D. Roy, S. K. Pore, R. Banerjee, J. Mahesh Kumar, R. K. Thakur, et al. (2014)
Nucleic Acids Res. 42, 764-773
   Abstract »    Full Text »    PDF »
Phenotypic Screens Targeting Neurodegenerative Diseases.
M. Zhang, G. Luo, Y. Zhou, S. Wang, and Z. Zhong (2014)
J Biomol Screen 19, 1-16
   Abstract »    Full Text »    PDF »
Assessing compound carcinogenicity in vitro using connectivity mapping.
F. Caiment, M. Tsamou, D. Jennen, and J. Kleinjans (2014)
Carcinogenesis 35, 201-207
   Abstract »    Full Text »    PDF »
Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.
H. Ding, J. S. McDonald, S. Yun, P. A. Schneider, K. L. Peterson, K. S. Flatten, D. A. Loegering, A. L. Oberg, S. M. Riska, S. Huang, et al. (2014)
Haematologica 99, 60-69
   Abstract »    Full Text »    PDF »
gCMAP: user-friendly connectivity mapping with R.
T. Sandmann, S. K. Kummerfeld, R. Gentleman, and R. Bourgon (2014)
Bioinformatics 30, 127-128
   Abstract »    Full Text »    PDF »
Comparison of Methods for Image-Based Profiling of Cellular Morphological Responses to Small-Molecule Treatment.
V. Ljosa, P. D. Caie, R. ter Horst, K. L. Sokolnicki, E. L. Jenkins, S. Daya, M. E. Roberts, T. R. Jones, S. Singh, A. Genovesio, et al. (2013)
J Biomol Screen 18, 1321-1329
   Abstract »    Full Text »    PDF »
Benchmarking of Multivariate Similarity Measures for High-Content Screening Fingerprints in Phenotypic Drug Discovery.
F. Reisen, X. Zhang, D. Gabriel, and P. Selzer (2013)
J Biomol Screen 18, 1284-1297
   Abstract »    Full Text »    PDF »
Ontology-aware classification of tissue and cell-type signals in gene expression profiles across platforms and technologies.
Y.-s. Lee, A. Krishnan, Q. Zhu, and O. G. Troyanskaya (2013)
Bioinformatics 29, 3036-3044
   Abstract »    Full Text »    PDF »
Toxygates: interactive toxicity analysis on a hybrid microarray and linked data platform.
J. Nystrom-Persson, Y. Igarashi, M. Ito, M. Morita, N. Nakatsu, H. Yamada, and K. Mizuguchi (2013)
Bioinformatics 29, 3080-3086
   Abstract »    Full Text »    PDF »
Gene Expression Profile and Functional Analysis of Alzheimer's Disease.
F. Chen, Q. Guan, Z.-Y. Nie, and L.-J. Jin (2013)
American Journal of Alzheimer's Disease and Other Dementias 28, 693-701
   Abstract »    Full Text »    PDF »
DEXUS: identifying differential expression in RNA-Seq studies with unknown conditions.
G. Klambauer, T. Unterthiner, and S. Hochreiter (2013)
Nucleic Acids Res. 41, e198
   Abstract »    Full Text »    PDF »
Using Functional Signature Ontology (FUSION) to Identify Mechanisms of Action for Natural Products.
M. B. Potts, H. S. Kim, K. W. Fisher, Y. Hu, Y. P. Carrasco, G. B. Bulut, Y.-H. Ou, M. L. Herrera-Herrera, F. Cubillos, S. Mendiratta, et al. (2013)
Science Signaling 6, ra90
   Abstract »    Full Text »    PDF »
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer.
M. E. Abazeed, D. J. Adams, K. E. Hurov, P. Tamayo, C. J. Creighton, D. Sonkin, A. O. Giacomelli, C. Du, D. F. Fries, K.-K. Wong, et al. (2013)
Cancer Res. 73, 6289-6298
   Abstract »    Full Text »    PDF »
FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function.
I. Shats, M. L. Gatza, B. Liu, S. P. Angus, L. You, and J. R. Nevins (2013)
Cancer Res. 73, 6056-6067
   Abstract »    Full Text »    PDF »
Automated QuantMap for rapid quantitative molecular network topology analysis.
W. Schaal, U. Hammerling, M. G. Gustafsson, and O. Spjuth (2013)
Bioinformatics 29, 2369-2370
   Abstract »    Full Text »    PDF »
The thyroid cancer PAX8-PPARG fusion protein activates Wnt/TCF-responsive cells that have a transformed phenotype.
D. Vu-Phan, V. Grachtchouk, J. Yu, L. A. Colby, M. S. Wicha, and R. J. Koenig (2013)
Endocr. Relat. Cancer 20, 725-739
   Abstract »    Full Text »    PDF »
Towards building a disease-phenotype knowledge base: extracting disease-manifestation relationship from literature.
R. Xu, L. Li, and Q. Wang (2013)
Bioinformatics 29, 2186-2194
   Abstract »    Full Text »    PDF »
DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula.
A. Lagunin, S. Ivanov, A. Rudik, D. Filimonov, and V. Poroikov (2013)
Bioinformatics 29, 2062-2063
   Abstract »    Full Text »    PDF »
Similarity-based machine learning methods for predicting drug-target interactions: a brief review.
H. Ding, I. Takigawa, H. Mamitsuka, and S. Zhu (2013)
Brief Bioinform
   Abstract »    Full Text »    PDF »
Heterogeneity in Neutrophil Microparticles Reveals Distinct Proteome and Functional Properties.
J. Dalli, T. Montero-Melendez, L. V. Norling, X. Yin, C. Hinds, D. Haskard, M. Mayr, and M. Perretti (2013)
Mol. Cell. Proteomics 12, 2205-2219
   Abstract »    Full Text »    PDF »
Network2Canvas: network visualization on a canvas with enrichment analysis.
C. M. Tan, E. Y. Chen, R. Dannenfelser, N. R. Clark, and A. Ma'ayan (2013)
Bioinformatics 29, 1872-1878
   Abstract »    Full Text »    PDF »
Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State.
S. Santagata, M. L. Mendillo, Y.-c. Tang, A. Subramanian, C. C. Perley, S. P. Roche, B. Wong, R. Narayan, H. Kwon, M. Koeva, et al. (2013)
Science 341, 1238303
   Abstract »    Full Text »    PDF »
The UCSC Interaction Browser: multidimensional data views in pathway context.
C. K. Wong, C. J. Vaske, S. Ng, J. Z. Sanborn, S. C. Benz, D. Haussler, and J. M. Stuart (2013)
Nucleic Acids Res. 41, W218-W224
   Abstract »    Full Text »    PDF »
Protein Sets Define Disease States and Predict In Vivo Effects of Drug Treatment.
D. Meierhofer, C. Weidner, L. Hartmann, J. A. Mayr, C.-T. Han, F. C. Schroeder, and S. Sauer (2013)
Mol. Cell. Proteomics 12, 1965-1979
   Abstract »    Full Text »    PDF »
From Integrative Genomics to Therapeutic Targets.
R. Natrajan and P. Wilkerson (2013)
Cancer Res. 73, 3483-3488
   Abstract »    Full Text »    PDF »
Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model.
H. A. F. Stessman, L. B. Baughn, A. Sarver, T. Xia, R. Deshpande, A. Mansoor, S. A. Walsh, J. J. Sunderland, N. G. Dolloff, M. A. Linden, et al. (2013)
Mol. Cancer Ther. 12, 1140-1150
   Abstract »    Full Text »    PDF »
Towards a bioinformatics analysis of anti-Alzheimer's herbal medicines from a target network perspective.
Y. Sun, R. Zhu, H. Ye, K. Tang, J. Zhao, Y. Chen, Q. Liu, and Z. Cao (2013)
Brief Bioinform 14, 327-343
   Abstract »    Full Text »    PDF »
Renoprotective Effect of Combined Inhibition of Angiotensin-Converting Enzyme and Histone Deacetylase.
Y. Zhong, E. Y. Chen, R. Liu, P. Y. Chuang, S. K. Mallipattu, C. M. Tan, N. R. Clark, Y. Deng, P. E. Klotman, A. Ma'ayan, et al. (2013)
J. Am. Soc. Nephrol. 24, 801-811
   Abstract »    Full Text »    PDF »
High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition.
E. Wik, E. Birkeland, J. Trovik, H. M. J. Werner, E. A. Hoivik, S. Mjos, C. Krakstad, K. Kusonmano, K. Mauland, I. M. Stefansson, et al. (2013)
Clin. Cancer Res. 19, 2331-2341
   Abstract »    Full Text »    PDF »
The Clinical Relevance of Cancer Cell Lines.
J.-P. Gillet, S. Varma, and M. M. Gottesman (2013)
J Natl Cancer Inst 105, 452-458
   Abstract »    Full Text »    PDF »
The Multidimensional Perturbation Value: A Single Metric to Measure Similarity and Activity of Treatments in High-Throughput Multidimensional Screens.
J. E. Hutz, T. Nelson, H. Wu, G. McAllister, I. Moutsatsos, S. A. Jaeger, S. Bandyopadhyay, F. Nigsch, B. Cornett, J. L. Jenkins, et al. (2013)
J Biomol Screen 18, 367-377
   Abstract »    Full Text »    PDF »
Drug interaction networks: an introduction to translational and clinical applications.
F. Azuaje (2013)
Cardiovasc Res 97, 631-641
   Abstract »    Full Text »    PDF »
Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis.
C. A. Patwardhan, A. Fauq, L. B. Peterson, C. Miller, B. S. J. Blagg, and A. Chadli (2013)
J. Biol. Chem. 288, 7313-7325
   Abstract »    Full Text »    PDF »
Concise Review: New Paradigms for Down Syndrome Research Using Induced Pluripotent Stem Cells: Tackling Complex Human Genetic Disease.
J. A. Briggs, E. A. Mason, D. A. Ovchinnikov, C. A. Wells, and E. J. Wolvetang (2013)
Stem Cells Trans Med 2, 175-184
   Abstract »    Full Text »    PDF »
Lack of Estrogen Receptor-{alpha} Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma.
E. Wik, M. B. Raeder, C. Krakstad, J. Trovik, E. Birkeland, E. A. Hoivik, S. Mjos, H. M. J. Werner, M. Mannelqvist, I. M. Stefansson, et al. (2013)
Clin. Cancer Res. 19, 1094-1105
   Abstract »    Full Text »    PDF »
Second act.
P. Nair (2013)
PNAS 110, 2430-2432
   Full Text »    PDF »
Defining principles of combination drug mechanisms of action.
J. R. Pritchard, P. M. Bruno, L. A. Gilbert, K. L. Capron, D. A. Lauffenburger, and M. T. Hemann (2013)
PNAS 110, E170-E179
   Abstract »    Full Text »    PDF »
Modelling how initiating and transforming oncogenes cooperate to produce a leukaemic cell state.
S. E. Richardson (2013)
Dis. Model. Mech. 6, 3-5
   Full Text »    PDF »
Global cellular response to chemotherapy-induced apoptosis.
A. P. Wiita, E. Ziv, P. J. Wiita, A. Urisman, O. Julien, A. L. Burlingame, J. S. Weissman, and J. A. Wells (2013)
eLife Sci 2, e01236
   Abstract »    Full Text »    PDF »
NetwoRx: connecting drugs to networks and phenotypes in Saccharomyces cerevisiae.
K. Fortney, W. Xie, M. Kotlyar, J. Griesman, Y. Kotseruba, and I. Jurisica (2013)
Nucleic Acids Res. 41, D720-D727
   Abstract »    Full Text »    PDF »
RhesusBase: a knowledgebase for the monkey research community.
S.-J. Zhang, C.-J. Liu, M. Shi, L. Kong, J.-Y. Chen, W.-Z. Zhou, X. Zhu, P. Yu, J. Wang, X. Yang, et al. (2013)
Nucleic Acids Res. 41, D892-D905
   Abstract »    Full Text »    PDF »
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.
E. Martin-Sanchez, S. M. Rodriguez-Pinilla, M. Sanchez-Beato, L. Lombardia, B. Dominguez-Gonzalez, D. Romero, L. Odqvist, P. Garcia-Sanz, M. B. Wozniak, G. Kurz, et al. (2013)
Haematologica 98, 57-64
   Abstract »    Full Text »    PDF »
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?.
E. A. Raetz and T. Bhatla (2012)
Hematology 2012, 129-136
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882